ONC vs VRSK Comparison

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.

Verisk Analytics is a leading provider of data analytics and proprietary solutions supporting clients in the insurance ecosystem. Verisk operates under a single segment with two separate business units, underwriting and claims. Within underwriting, the company operates as both a statistical agent and advisory organization, collecting and aggregating industrywide claims and policy data and providing insurers with preapproved forms, rules, and loss costs. Aside from regulatory and compliance offerings, Verisk provides specialized solutions to power P&C underwriting and catastrophe risk assessment used in reinsurance and insurance-linked securities. Verisk's smaller claims business is critical in preventing fraud and estimating property insurance claims.